Beyond Chemotherapy: The Rise of Targeted and Immuno-therapies in the Oncology Drugs Market
For decades, the standard of care for cancer was a "scorched earth" approach—using chemotherapy to kill rapidly dividing cells, both healthy and malignant. Today, the field of oncology is undergoing a dramatic shift toward precision. We are entering an era of targeted therapies and immunotherapies that act like guided missiles, attacking the specific molecular drivers of a tumor or...
0 Comentários 0 Compartilhamentos 34 Visualizações 0 Anterior